Lawrence A. Rheins Ph.D.
About Lawrence A. Rheins Ph.D.
Chief Scientific Officer
Lawrence A. Rheins, Ph.D., serves as the Chief Scientific Officer. In this role, he oversees scientific research efforts and product development. His leadership focuses on advancing scientific understanding and ensuring that research findings are effectively translated into practical applications.
Educational Background and Ph.D.
Lawrence A. Rheins holds a Ph.D., bringing a high level of academic expertise to his professional endeavors. His advanced education underpins his work in scientific research and product development, contributing to innovations in his field.
Co-author of Study on Platelet Homeostasis
Lawrence A. Rheins co-authored a study on the role of platelet homeostasis in a novel topical PRP formulation. This study contributes valuable insights into the development and efficacy of platelet-rich plasma treatments, emphasizing his role in advancing medical research and clinical applications.
Clinical Research and Peer-Reviewed Publications
Lawrence A. Rheins is actively involved in clinical research and has a history of publishing peer-reviewed studies. His research work adds significant value to the scientific community, demonstrating his commitment to advancing knowledge through rigorous study and scholarly collaboration.
Expertise in Vivace Ultra™ and SoME® Skincare
Lawrence A. Rheins has substantial expertise in understanding the evolution of Vivace Ultra™ and SoME® Skincare. His insight into these products highlights his involvement in developing innovative skincare solutions and his role in promoting advancements in dermatological treatments.